ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
IssuerBlackrock
ETF TickerBTEE(USD) LSE
ETF TickerBTEE.L(GBP) LSE

Holdings detail for CRBU

Stock NameCaribou Biosciences Inc
TickerCRBU(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS1420381089

Show aggregate CRBU holdings

News associated with CRBU

Cambridge Investment Research Advisors Inc. Makes New $559,000 Investment in Caribou Biosciences, Inc. (NASDAQ:CRBU)
Cambridge Investment Research Advisors Inc. bought a new position in Caribou Biosciences, Inc. (NASDAQ:CRBU – Free Report) in the first quarter, Holdings Channel reports. The institutional investor bought 612,412 shares of the company’s stock, valued at approximately $559,000. Other hedge funds and other institutional investors have also modified their holdings of the company. US Bancorp […] - 2025-07-09 04:40:02
Caribou Biosciences, Inc. (NASDAQ:CRBU) Stock Holdings Boosted by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC boosted its holdings in Caribou Biosciences, Inc. (NASDAQ:CRBU – Free Report) by 51.4% during the 1st quarter, Holdings Channel reports. The fund owned 124,889 shares of the company’s stock after acquiring an additional 42,395 shares during the quarter. Exchange Traded Concepts LLC’s holdings in Caribou Biosciences were worth $114,000 as of […] - 2025-06-25 04:57:01
Nuveen Asset Management LLC Increases Stock Position in Caribou Biosciences, Inc. (NASDAQ:CRBU)
Nuveen Asset Management LLC raised its holdings in Caribou Biosciences, Inc. (NASDAQ:CRBU – Free Report) by 23.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 330,831 shares of the company’s stock after purchasing an additional 63,096 shares during the period. Nuveen Asset […] - 2025-06-06 04:54:52
Barclays PLC Purchases 15,578 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU)
Barclays PLC raised its position in Caribou Biosciences, Inc. (NASDAQ:CRBU – Free Report) by 12.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 145,417 shares of the company’s stock after acquiring an additional 15,578 shares during the quarter. Barclays PLC’s holdings in Caribou Biosciences […] - 2025-05-13 04:34:54
Comparing Caribou Biosciences (NASDAQ:CRBU) and Invizyne Technologies (NASDAQ:IZTC)
Caribou Biosciences (NASDAQ:CRBU – Get Free Report) and Invizyne Technologies (NASDAQ:IZTC – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, valuation, analyst recommendations and earnings. Institutional & Insider Ownership 77.5% of Caribou […] - 2025-05-08 02:04:51
Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Bought by Russell Investments Group Ltd.
Russell Investments Group Ltd. lifted its holdings in shares of Caribou Biosciences, Inc. (NASDAQ:CRBU – Free Report) by 859.0% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 23,909 shares of the company’s stock after purchasing an additional 21,416 shares during the quarter. Russell Investments Group Ltd.’s […] - 2025-04-28 04:42:57
Caribou Biosciences, Inc. (NASDAQ:CRBU) Given Consensus Recommendation of “Buy” by Brokerages
Caribou Biosciences, Inc. (NASDAQ:CRBU – Get Free Report) has been assigned a consensus recommendation of “Buy” from the five analysts that are covering the firm, MarketBeat reports. Five investment analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have issued a report on the stock in the […] - 2025-04-17 04:43:10
Head to Head Review: Caribou Biosciences (NASDAQ:CRBU) & Atyr PHARMA (NASDAQ:ATYR)
Caribou Biosciences (NASDAQ:CRBU – Get Free Report) and Atyr PHARMA (NASDAQ:ATYR – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation. Valuation and Earnings This table compares Caribou […] - 2025-02-07 04:32:51

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) CRBU holdings

DateNumber of CRBU Shares HeldBase Market Value of CRBU SharesLocal Market Value of CRBU SharesChange in CRBU Shares HeldChange in CRBU Base ValueCurrent Price per CRBU Share HeldPrevious Price per CRBU Share Held
2026-02-09 (Monday)65,375USD 106,561USD 106,561
2026-02-06 (Friday)65,234CRBU holding increased by 142USD 102,417CRBU holding increased by 7383USD 102,417142USD 7,383 USD 1.56999 USD 1.46
2026-02-02 (Monday)65,092USD 95,034CRBU holding increased by 3254USD 95,0340USD 3,254 USD 1.46 USD 1.41
2026-01-30 (Friday)65,092CRBU holding increased by 284USD 91,780CRBU holding decreased by -4136USD 91,780284USD -4,136 USD 1.41 USD 1.48
2026-01-29 (Thursday)64,808CRBU holding increased by 142USD 95,916CRBU holding decreased by -4316USD 95,916142USD -4,316 USD 1.48 USD 1.55
2026-01-27 (Tuesday)64,666CRBU holding increased by 144USD 100,232CRBU holding increased by 1513USD 100,232144USD 1,513 USD 1.55 USD 1.53001
2026-01-26 (Monday)64,522USD 98,719USD 98,7190USD 0 USD 1.53001 USD 1.53001
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CRBU by Blackrock for IE00BDZVHG35

Show aggregate share trades of CRBU

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-02-06BUY142 1.570* -
2026-01-30BUY2841.4701.390 1.398USD 397 -
2026-01-29BUY1421.5301.465 1.472USD 209 -
2026-01-27BUY1441.5801.515 1.521USD 219 -
2026-01-23BUY2861.6301.530 1.540USD 440 -
2026-01-22BUY1431.6451.485 1.501USD 215 -
2026-01-15BUY3041.6301.550 1.558USD 474 -
2026-01-14BUY3041.6201.580 1.584USD 482 -
2026-01-12BUY3041.6501.520 1.533USD 466 -
2026-01-09BUY4561.7301.640 1.649USD 752 -
2026-01-07BUY3041.8001.695 1.706USD 518 -
2026-01-02BUY1521.6001.540 1.546USD 235 -
2025-12-30BUY1521.6501.580 1.587USD 241 -
2025-12-23SELL-8841.7201.630 1.639USD -1,449 -
2025-12-22BUY1,3321.7351.670 1.676USD 2,233 -
2024-11-18SELL-2,3401.9802.089 2.078USD -4,863 -
2024-11-08SELL-1562.6802.950 2.923USD -456 -
2024-10-21SELL-1561.9702.010 2.006USD -313 -
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CRBU

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19215,102500486,79544.2%
2025-09-18226,67101,242,81318.2%
2025-09-17169,3290547,08931.0%
2025-09-16231,347160676,68834.2%
2025-09-15149,1090221,81567.2%
2025-09-12213,6150359,38759.4%
2025-09-11124,859600292,07042.7%
2025-09-1098,8463,178235,82741.9%
2025-09-09155,843382279,44255.8%
2025-09-08111,5510255,17643.7%
2025-09-0579,0220232,87633.9%
2025-09-04141,7651,418340,02441.7%
2025-09-0374,2380179,29941.4%
2025-09-02117,8880221,50853.2%
2025-08-2990,4870244,12137.1%
2025-08-28158,096139559,40828.3%
2025-08-27287,1522,650775,99737.0%
2025-08-26182,7940501,05836.5%
2025-08-2596,6832,628282,42234.2%
2025-08-22244,4960793,57930.8%
2025-08-2169,43724,250238,51729.1%
2025-08-2063,3550200,35231.6%
2025-08-19221,8840475,21146.7%
2025-08-18275,9890784,01235.2%
2025-08-15295,1898,869618,43347.7%
2025-08-14392,8940765,96951.3%
2025-08-13142,1920832,01917.1%
2025-08-1249,7370359,23313.8%
2025-08-1158,8750259,65022.7%
2025-08-08107,9592,450351,61430.7%
2025-08-07158,724401638,15624.9%
2025-08-06271,4787,218812,89133.4%
2025-08-05127,4780548,17523.3%
2025-08-04132,7950502,51426.4%
2025-08-01121,48529609,82319.9%
2025-07-31164,5480715,31723.0%
2025-07-30222,51029,421843,67126.4%
2025-07-29479,21296,1631,981,90824.2%
2025-07-28222,1841,671958,92523.2%
2025-07-25178,8151,248872,23320.5%
2025-07-24279,7853,7611,158,73524.1%
2025-07-23324,37311,2521,677,32519.3%
2025-07-22383,7317,7561,316,77529.1%
2025-07-21381,1391631,418,92626.9%
2025-07-18406,79218,8691,814,70522.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy